CASRAI Dictionary

Tag: mrc grants awarded

  • MRC Grants Awarded: How to Read the Register

    MRC grants awarded data is published across three separate UKRI sources — Gateway to Research, the legacy Grants on the Web (GOTW) register, and MRC’s board and panel outcomes pages — and reading it correctly for benchmarking means matching each source to a different question: what was funded, who applied, and how competitive each specific panel meeting was.

    The MRC grants awarded register is the collective term for the public funding-decision records that UK Research and Innovation (UKRI) publishes for the Medical Research Council, spanning historical award spreadsheets, a live searchable grants database, and meeting-by-meeting board and panel outcome listings. For research office staff building competitor intelligence or benchmarking their institution’s success against peers, the register is genuinely useful — but only if its structure and its stated caveats are understood before the numbers are used.

    What is the MRC grants awarded register?

    There is no single document called the “MRC grants awarded register” — it is a set of linked publications UKRI maintains under its “What MRC has funded” pages. These cover awarded grants and fellowships from April 2006 to December 2019 as a downloadable spreadsheet, interactive Tableau dashboards for 2022–23 funding decisions, and rolling board and panel outcome listings for funding meetings from 2017 onward, with earlier records held in the UK Government Web Archive.

    Before 2018, MRC referred to this material as “success rates”; UKRI has since folded the reporting into the wider board and panel outcomes format used across all seven research councils. Any benchmarking exercise therefore has to account for a terminology and format change partway through the period being analysed.

    Where to find MRC grants-awarded data: three sources compared

    Three distinct tools hold MRC award data, and each answers a different research-intelligence question. Confusing them is the single most common reading error institutions make when building competitor comparisons.

    Source What it covers Update pattern Best use
    Gateway to Research Full award records once a grant has started, including principal investigator, institution and value, across all UKRI councils Continuous, as grants start Cross-council portfolio and competitor analysis
    Grants on the Web (GOTW) Legacy register of MRC-administered grants, fellowships and training grants, filterable by institution Static; predates the UKRI merger Institution-level historical lookups
    Board and panel outcomes Score out of ten and funding decision for every application discussed at a given meeting Usually within four weeks of each meeting Competitive positioning within a specific funding round
    Archived spreadsheet and success-rate data Award listings April 2006–December 2019 and pre-2018 success-rate summaries Frozen, held on the UK Government Web Archive Long-run trend analysis

    For most benchmarking work, Gateway to Research and the board and panel outcomes pages should be the primary pair: the former gives the awarded portfolio, the latter gives the competitive context each award was won against.

    How to read board and panel outcomes for benchmarking

    MRC scores every application from one to ten, with ten the best, and this scoring structure applies across all types of MRC funding meeting. Applications are then listed in numerical order within blocks according to their median score group and funding decision, according to UKRI’s published board and panel outcomes guidance.

    Outcomes are usually published within four weeks of a meeting, though UKRI notes this can sometimes take longer. Crucially, applications that are unsuccessful after an earlier shortlisting stage are not discussed at the funding meeting and are therefore not included in board and panel outcomes at all — a data-quality point that matters enormously for anyone computing a success rate, since the visible denominator understates total submissions.

    • Score and decision are recorded per application, not per institution, so institution-level rates must be aggregated manually.
    • Shortlisting-stage rejections are invisible in this dataset — factor this into any success-rate calculation.
    • Full award detail (value, abstract, classification) only appears on Gateway to Research once the grant has actually started.

    How to benchmark success rates and competitor institutions correctly

    UKRI states explicitly that funding decisions are made “in circumstances unique to each panel meeting” and that the funding cut-off is dependent on the budget available at that specific meeting — not a fixed quality threshold. UKRI’s guidance is direct: institutions should not compare funding cut-off points made in different meetings, and UKRI will not consider challenges or enquiries based on such comparisons.

    This has a practical consequence for benchmarking: a proposal scoring 7/10 that was funded in a budget-flush round and a proposal scoring 8/10 declined in a tighter round are not evidence that the second panel was harsher. A robust competitor-analysis method therefore favours relative, within-round comparisons — an institution’s share of awards made at a given meeting, or across a given scheme over several rounds — over any single cross-period success-rate percentage pulled from a headline figure.

    Combining Gateway to Research (what was funded), board and panel outcomes (how competitive that round was), and GOTW’s institution filter (a second, independent cross-check for MRC-specific awards) gives a defensible three-source method rather than a single-source snapshot.

    Common questions on reading the MRC register

    How do I search MRC grants awarded by institution?

    Use Grants on the Web (GOTW), the legacy register hosted at gotw.nerc.ac.uk, and filter by “Institution > Medical Research Council (MRC)”; each project links to the full grant record, including principal investigator and value. For more current, cross-council records, Gateway to Research offers the same institution-level filtering.

    Where can I find MRC board and panel outcomes?

    UKRI publishes MRC’s board and panel outcomes in the “What MRC has funded” section of ukri.org, usually within four weeks of each funding meeting. Outcomes list every application discussed, its score out of ten and its funding decision, allowing panel-by-panel benchmarking rather than reliance on one headline figure.

    Is there a live MRC grants search tool?

    Gateway to Research is UKRI’s live, searchable database of funded projects across all seven research councils, updated continuously as grants start. Grants on the Web remains a parallel legacy tool for MRC-administered awards, useful for cross-checking older or training-grant records.

    Can I compare MRC funding cut-off scores between panel meetings?

    No — UKRI explicitly advises against this. Each meeting’s funding cut-off depends solely on the budget available at that specific meeting, not a fixed quality bar, so scores funded in one round and declined in another are not directly comparable as evidence of relative panel rigour.

    Implications for research offices and what happens next

    For research administration and funding-intelligence teams, the practical implication is that MRC grants-awarded data supports rigorous benchmarking only when the three sources are triangulated and UKRI’s own comparability caveats are respected. A single downloaded spreadsheet or a bare success-rate percentage, taken in isolation, will systematically misrepresent competitive position because of the shortlisting-stage exclusion and the meeting-specific funding cut-off.

    UKRI last updated its board and panel outcomes guidance on 3 March 2026 and its “What MRC has funded” summary page on 29 September 2025, and continues to migrate historical reporting into Tableau-based dashboards — most recently for 2025 panel outcomes and attendance. Institutions building recurring funding-intelligence dashboards should expect this format to keep evolving, and should re-check source URLs each reporting cycle rather than hard-coding links to any single spreadsheet. Research administration teams that build this triangulated method once can reuse it across other UKRI councils, since board and panel outcomes reporting now follows a common structure council-wide.

  • MRC Funding Update UKRI: Grants Reopened

    MRC funding update, in brief: the Medical Research Council paused several applicant-led grant schemes from February 2026 while UK Research and Innovation restructured to an “always open” application model; research grants, new investigator grants and partnership grants reopened on 7 April 2026, experimental medicine opportunities reopened on 30 April 2026, and MRC Proof of Concept and Impact Acceleration Awards are scheduled to reopen in July 2026. For grant holders, the practical implications are a new rolling submission window, a consolidated review structure, and firm caps on how many applications one person can lead at once.

    The MRC funding update ukri has published since February 2026 marks the most significant procedural change to Medical Research Council grant administration in over a decade. Medical Research Council (MRC) is one of UK Research and Innovation’s seven disciplinary councils, responsible for funding biomedical and health research across the UK’s higher education and institute sector. This briefing sets out exactly what changed, what remains open, and what research administrators and principal investigators need to do differently when planning 2026 applications.

    What actually changed in the MRC funding update

    On 1 February 2026, UKRI Chief Executive Ian Chapman issued an open letter to the research and innovation community announcing a new investment approach for the 2026–2030 spending review period. The letter described a shift toward a “more strategic, UKRI-wide model” for funding decisions, and confirmed that MRC would use the transition to refresh its approach to applicant-led funding.

    The headline structural change is a move to an “always open” responsive-mode system, replacing fixed application deadlines. UKRI states that published deadlines “cause significant variation in the volume of applications we receive and in reviewer availability,” and that removing them smooths these peaks and troughs. This is an operating-model change, not a funding cut — MRC says curiosity-driven research remains a committed priority, underpinned by a UKRI-wide 50% budget commitment to that category of research.

    To implement the “always open” system, MRC had to pause several applicant-led funding opportunities from February 2026 while the assessment infrastructure was rebuilt. Awards that had already been offered, accepted or started were explicitly unaffected throughout the transition.

    Reopening timeline: what’s open now and what’s still paused

    As of the most recent UKRI update (15 June 2026), most MRC applicant-led schemes have reopened. Grant holders should treat the table below as the operative reference, not the earlier February pause notice, which is now superseded.

    MRC funding opportunity Status Reopening date
    Applicant-led research grants Open 7 April 2026
    New investigator research grants Open 7 April 2026
    Partnership grants (applicant-led) Open 7 April 2026
    Experimental medicine opportunities Open 30 April 2026
    MRC Proof of Concept (formerly Developmental Pathway Funding Scheme, stage one) Reopening July 2026
    MRC Impact Acceleration Awards (formerly MRC Gap Fund) Reopening July 2026
    Fellowships, studentships, Centres of Research Excellence Never paused Continuously open

    UKRI expects the wider transition to be complete by the start of the 2027–2028 financial year (6 April 2027 to 5 April 2028). Institutions running internal peer-review or costing pipelines timed to the old deadline calendar should recalibrate now: under “always open” mode, there is no annual cycle to plan around.

    The new College of Experts review structure

    MRC’s four disciplinary research boards — covering infections and immunity, molecular and cellular medicine, neurosciences and mental health, and population and systems medicine — have been consolidated into a single College of Experts. Funding panels are now drawn flexibly from this combined pool rather than fixed to a single board.

    This restructuring supports cross-disciplinary applications that previously sat awkwardly between boards, and enables faster decisions by decoupling panel composition from a rigid quarterly schedule. Applications closed before the transition — including the legacy boards’ November 2025 round and Developmental Pathway Funding Scheme stage two — are still assessed under the old structure, with decisions expected in April 2026; MRC has confirmed a reduced number of awards from that backlog, reflecting the changeover rather than any change in typical grant size going forward.

    Application caps and resubmission rules grant holders must know

    Two new eligibility mechanics apply under the “always open” model and directly affect how principal investigators should sequence their applications:

    • Application cap: a maximum of two applications as project lead may be submitted across applicant-led responsive-mode funding calls within any rolling 12-month period.
    • Resubmission bar: an application previously unsuccessful with MRC — or with any other funder — will not be considered again for 12 months, unless MRC has explicitly invited a resubmission.
    • Cost basis unchanged: MRC continues to fund 80% of the full economic cost (FEC), with grant durations ranging from 18 months to five years and no fixed cap on requested amount, provided the sum is proportionate to project scope.

    For research offices, “always open” does not mean unlimited throughput per investigator — it shifts the constraint from a calendar deadline to a rolling personal quota. Grant-writing capacity planning built around a fixed autumn or spring deadline now needs continuous tracking of each investigator’s rolling 12-month application count.

    Budget signals: what the wider UKRI settlement means

    UKRI has stated that its overall research and innovation budget is rising across the 2026–2030 spending review period, and that the budget for biomedical and health research specifically is “in an excellent position.” Independent analysis from the Campaign for Science and Engineering notes that the overall UKRI budget is set to rise toward £10 billion a year by 2030, though how that funding is distributed across councils and themes is shifting considerably as part of the same restructuring.

    A parallel strand channels additional funding through the UKRI Life Sciences Priority Programme — a cross-council theme through which MRC accesses coordinated funding beyond its standalone curiosity-driven allocation. UKRI frames this as additive: fellowships, studentships and Centres of Research Excellence funding was unaffected throughout, and the pause applied only to specific applicant-led schemes during infrastructure changes.

    BBSRC underwent the same “always open” transition in parallel; its new investigator award and standard research grant have also reopened. Grant holders working across MRC and BBSRC funding lines should expect the same rolling-quota and resubmission mechanics on both councils, since the operating model is shared across the UKRI-wide transition rather than council-specific.

    Frequently asked questions

    Why did MRC pause its funding opportunities in 2026?

    MRC paused several applicant-led schemes from February 2026 to implement UKRI’s move to an “always open” application system. UKRI stated that fixed deadlines caused uneven application volumes and reviewer availability problems, and that removing them required behind-the-scenes changes to assessment infrastructure before reopening.

    Which MRC grants have reopened?

    Applicant-led research grants, new investigator research grants and partnership grants reopened on 7 April 2026, and experimental medicine opportunities reopened on 30 April 2026. MRC Proof of Concept and MRC Impact Acceleration Awards are scheduled to reopen in July 2026.

    Were MRC fellowships and studentships affected?

    No. MRC has confirmed that funding for fellowships, studentships, and MRC Centres of Research Excellence was not affected by the 2026 pause and remained continuously open for applications throughout the transition period.

    How many MRC applications can one person lead at once?

    Under the new rules, a principal investigator may lead a maximum of two applications across applicant-led responsive-mode funding calls within any rolling 12-month period, and unsuccessful applications face a 12-month resubmission bar unless MRC has invited one.

    Implications for institutions and grant holders

    Research offices should update three things now. First, replace deadline-driven internal sign-off calendars with continuous submission tracking, since “always open” removes the predictable peaks institutions have historically planned costing and QA cycles around. Second, build a per-investigator rolling application count into grants-management systems to enforce the two-applications-per-12-months cap before a proposal reaches MRC and is rejected on eligibility grounds. Third, brief investigators explicitly on the 12-month resubmission bar — a previously unsuccessful proposal, even a strong one, is not eligible for quick resubmission without an explicit MRC invitation, which changes revision strategy considerably.

    MRC has said it will continue to share updates and reopen remaining funding opportunities as they become ready, with full transition to the new model expected by April 2027. Institutions with active or upcoming submissions should monitor the MRC application timeline directly rather than relying on the February 2026 pause notice, which the June 2026 update has substantially superseded.